within Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M01A_AntiinflammatoryAndAntirheumaticProductsNonSteroids.M01AE07_Suprofen;

model Suprofen
  extends Pharmacolibrary.Drugs.ATC.M.M01AE07;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>M01AE07</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Suprofen is a nonsteroidal anti-inflammatory drug (NSAID) of the propionic acid class, previously used for the management of pain and inflammation, and as an ophthalmic solution to prevent miosis during eye surgery. Due to adverse renal effects, oral and systemic forms have been withdrawn from the market in most countries, though ophthalmic formulations were available for longer. It is not commonly used or approved for systemic use today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated for a typical healthy adult based on available secondary pharmacological sources and class similarity, as no primary PK study specific to suprofen has been located.</p><h4>References</h4><ol><li><p>Todd, PA, &amp; Heel, RC (1985). Suprofen. A review of its pharmacodynamic and pharmacokinetic properties, and analgesic efficacy. <i>Drugs</i> 30(6) 514–538. DOI:<a href=&quot;https://doi.org/10.2165/00003495-198530060-00004&quot;>10.2165/00003495-198530060-00004</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3908075/&quot;>https://pubmed.ncbi.nlm.nih.gov/3908075</a></p></li><li><p>Chaikin, P, et al., &amp; Weintraub, HS (1988). Comparative bioavailability of suprofen after coadministration with food or milk. <i>Journal of clinical pharmacology</i> 28(12) 1132–1135. DOI:<a href=&quot;https://doi.org/10.1002/j.1552-4604.1988.tb05730.x&quot;>10.1002/j.1552-4604.1988.tb05730.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3243932/&quot;>https://pubmed.ncbi.nlm.nih.gov/3243932</a></p></li><li><p>Shinohara, Y, et al., &amp; Baba, S (1991). Stereoselective pharmacokinetics and inversion of suprofen enantiomers in humans. <i>Journal of pharmaceutical sciences</i> 80(11) 1075–1078. DOI:<a href=&quot;https://doi.org/10.1002/jps.2600801116&quot;>10.1002/jps.2600801116</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1815060/&quot;>https://pubmed.ncbi.nlm.nih.gov/1815060</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Suprofen;
